STOCK TITAN

Cencora (COR) Stock News

COR NYSE

Welcome to our dedicated page for Cencora news (Ticker: COR), a resource for investors and traders seeking the latest updates and insights on Cencora stock.

Cencora, Inc. reports news around its role as a global pharmaceutical solutions organization that distributes branded, generic and specialty pharmaceuticals to pharmacies, hospital networks and healthcare providers. Company updates also cover commercialization services for pharmaceutical and medical-device manufacturers, specialty drug logistics through World Courier, animal health distribution through MWI Animal Health and international wholesale activity following the Alliance Healthcare acquisition.

Recurring developments include fiscal operating results, gross profit drivers, LIFO effects, GLP-1 product mix and performance in U.S. Healthcare Solutions. News also covers completed acquisitions such as OneOncology and Retina Consultants of America, senior note financing, shareholder and governance matters, and executive leadership transitions.

Rhea-AI Summary

Bandwidth Infrastructure Group (Bandwidth IG) announced its new service provision to CoreSite's Santa Clara Data Center Campus, a pivotal area for tech in Silicon Valley. This partnership aims to meet the rising demand for seamless connectivity driven by cloud computing and data-intensive applications. Bandwidth IG's Data Center Connect solution enhances connectivity options, supporting diverse interconnectivity needs. The Santa Clara campus boasts over 775,000 square feet of colocation space and access to numerous cloud and IT providers, positioning it as a key player in the data center market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
none

FAQ

What is the current stock price of Cencora (COR)?

The current stock price of Cencora (COR) is $274.97 as of May 22, 2026.

What is the market cap of Cencora (COR)?

The market cap of Cencora (COR) is approximately 51.6B.